← Back to Search

Contrast Agent

Focused Assessment with Sonography for Trauma (FAST) for Abdominal Trauma (BEFAST Trial)

Phase 4
Waitlist Available
Led By Laura Oh, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical suspicion of intra-abdominal injury
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day of exam
Awards & highlights

BEFAST Trial Summary

This trial is testing whether adding ultrasound contrast to the FAST exam (BEFAST) will improve its sensitivity for identifying solid organ injury in hemodynamically stable blunt abdominal trauma patients.

Eligible Conditions
  • Abdominal Trauma

BEFAST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
There is a concern that you have injury inside your belly.

BEFAST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day of exam
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day of exam for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Inter-rater reliability
Number of successful exams
Sensitivity of Detecting Solid Organ Injury
+1 more

BEFAST Trial Design

1Treatment groups
Experimental Treatment
Group I: Non-enhanced FAST exam followed by BEFAST examExperimental Treatment2 Interventions
Participants in the emergency department with hemodynamically stable blunt abdominal trauma will receive the standard of care Focused Assessment with Sonography for Trauma (FAST) exam followed by a Bubble-Enhanced FAST exam.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
1,2-Distearoyllecithin
FDA approved
Focused Assessment with Sonography for Trauma (FAST)
2021
Completed Phase 4
~270

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,627 Previous Clinical Trials
2,560,498 Total Patients Enrolled
United States Department of DefenseFED
856 Previous Clinical Trials
225,328 Total Patients Enrolled
1 Trials studying Abdominal Trauma
150 Patients Enrolled for Abdominal Trauma
Laura Oh, MDPrincipal InvestigatorEmory University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has Focused Assessment with Sonography for Trauma been granted authorization by the FDA?

"Based on the advanced stage of clinical trials, our team has assigned FAST a score of 3 to denote its approved status as a safe and effective treatment."

Answered by AI

How many participants have been recruited for this trial?

"Affirmative. Clinicaltrials.gov illustrates that this medical trial is actively searching for participants, having initially been posted on September 30th 2021 and recently updated on October 13th 2022. 267 people are needed to take part in the research at a single site."

Answered by AI

Does this clinical research offer a unique approach?

"The research surrounding Focused Assessment with Sonography for Trauma (FAST) began in 2017, when it was sponsored by Bracco Diagnostics Inc. and completed its first trial involving 125 participants. Following the successful completion of this initial study, Phase < 1 drug approval was granted to Focused Assessment with Sonography for Trauma (FAST), leading to 14 active trials being conducted across 3 nations and 10 cities today."

Answered by AI

Does this trial presently have open enrollment?

"According to the information hosted on clinicaltrials.gov, enrollment is still open for this medical trial which was initially posted on September 30th 2021 and most recently updated October 13 2022."

Answered by AI

Have researchers conducted any other explorations involving Focused Assessment with Sonography for Trauma (FAST)?

"Currently, 14 clinical trials have been initiated to evaluate Focused Assessment with Sonography for Trauma (FAST). Two of these initiatives are in their final stage, Phase 3. Most locations conducting the trial can be found in Philadelphia, Pennsylvania; however 18 centres across the US are participating in this research endeavour."

Answered by AI
~78 spots leftby Mar 2025